Bausch + Lomb Corp
BLCO15.745USD
+0.745+4.97%
收盤 11/05, 16:00（美東）報價延遲15分鐘
5.58B總市值
虧損本益比TTM
關於 Bausch + Lomb Corp 公司
Bausch + Lomb Corporation 是一家眼保健公司。其業務分爲三個部門：視力保健、製藥和外科。視力保健部門包括隱形眼鏡和消費者眼保健業務，包括隱形眼鏡護理產品、非處方眼藥水和眼部維生素。製藥部門包括用於術後治療和多種眼部疾病治療的仿製藥產品，例如青光眼、眼部炎症、眼高壓、乾眼症和視網膜疾病。外科部門包括用於治療白內障、角膜和玻璃體以及視網膜眼部疾病的醫療器械設備、耗材、儀器和技術，其中包括輸送系統、晶狀體乳化設備和其他用於白內障手術的手術器械和設備。其品牌包括 PreserVision、Biotrue、Artelac、Alaway、Mioclear、Ocuvite、ScoutPro、XIIDRA、Vyzulta、Lotemax、Prolensa、Minims、INFUSE 等。
Bausch + Lomb Corp簡介
公司代碼BLCO
公司名稱Bausch + Lomb Corp
上市日期May 06, 2022
CEOMr. Brenton L. (Brent) Saunders, J.D.
員工數量13500
證券類型Ordinary Share
年結日May 06
公司地址520 Applewood Crescent
城市VAUGHAN
上市交易所NYSE Consolidated
國家Canada
郵編L4K 4B4
電話19082552864
網址https://ir.bausch.com/
公司代碼BLCO
上市日期May 06, 2022
CEOMr. Brenton L. (Brent) Saunders, J.D.
Bausch + Lomb Corp公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Brenton L. (Brent) Saunders, J.D.
Mr. Brenton L. (Brent) Saunders, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
352.13K
+162.32%
Mr. Luc Bonnefoy
Mr. Luc Bonnefoy
President - Surgical
President - Surgical
77.36K
+8.63%
Dr. Yehia Hashad, M.D.
Dr. Yehia Hashad, M.D.
Executive Vice President - Research & Development, Chief Medical Officer
Executive Vice President - Research & Development, Chief Medical Officer
68.18K
+35.10%
Mr. Russel C. Robertson
Mr. Russel C. Robertson
Independent Director
Independent Director
64.91K
+53.22%
Dr. Andrew Charles Von Eschenbach, M.D.
Dr. Andrew Charles Von Eschenbach, M.D.
Independent Director
Independent Director
62.09K
+55.01%
Mr. A. Robert D. Bailey, J.D.
Mr. A. Robert D. Bailey, J.D.
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
--
--
Ms. Sarah B. Kavanagh
Ms. Sarah B. Kavanagh
Independent Director
Independent Director
--
--
Mrs. Nathalie Bernier
Mrs. Nathalie Bernier
Independent Director
Independent Director
--
--
Mr. Andrew J. Stewart
Mr. Andrew J. Stewart
President - Global Pharmaceuticals and International Consumer
President - Global Pharmaceuticals and International Consumer
--
--
Mr. Sam A. Eldessouky
Mr. Sam A. Eldessouky
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Brenton L. (Brent) Saunders, J.D.
Mr. Brenton L. (Brent) Saunders, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
352.13K
+162.32%
Mr. Luc Bonnefoy
Mr. Luc Bonnefoy
President - Surgical
President - Surgical
77.36K
+8.63%
Dr. Yehia Hashad, M.D.
Dr. Yehia Hashad, M.D.
Executive Vice President - Research & Development, Chief Medical Officer
Executive Vice President - Research & Development, Chief Medical Officer
68.18K
+35.10%
Mr. Russel C. Robertson
Mr. Russel C. Robertson
Independent Director
Independent Director
64.91K
+53.22%
Dr. Andrew Charles Von Eschenbach, M.D.
Dr. Andrew Charles Von Eschenbach, M.D.
Independent Director
Independent Director
62.09K
+55.01%
Mr. A. Robert D. Bailey, J.D.
Mr. A. Robert D. Bailey, J.D.
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
--
--
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
OTC
482.00M
37.72%
Devices
472.00M
36.93%
Pharmaceuticals
260.00M
20.34%
Branded and other Generics
58.00M
4.54%
Other revenues
6.00M
0.47%
暫無數據
業務
地區
業務USD
名稱
營收
佔比
OTC
482.00M
37.72%
Devices
472.00M
36.93%
Pharmaceuticals
260.00M
20.34%
Branded and other Generics
58.00M
4.54%
Other revenues
6.00M
0.47%
股東統計
更新時間: 8月18日 週一
更新時間: 8月18日 週一
持股股東
股東類型
持股股東
持股股東
佔比
Bausch Health Companies Inc
87.68%
Icahn Associates Corporation
0.99%
Deutsche Bank Securities Inc.
0.96%
Alberta Investment Management Corporation
0.92%
D. E. Shaw & Co., L.P.
0.74%
其他
8.71%
持股股東
持股股東
佔比
Bausch Health Companies Inc
87.68%
Icahn Associates Corporation
0.99%
Deutsche Bank Securities Inc.
0.96%
Alberta Investment Management Corporation
0.92%
D. E. Shaw & Co., L.P.
0.74%
其他
8.71%
股東類型
持股股東
佔比
Corporation
87.68%
Hedge Fund
3.49%
Investment Advisor/Hedge Fund
3.31%
Research Firm
1.54%
Investment Advisor
1.52%
Sovereign Wealth Fund
0.92%
Individual Investor
0.48%
Pension Fund
0.25%
Family Office
0.24%
其他
0.57%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
246
39.05M
11.03%
-24.81M
2025Q2
263
350.71M
99.08%
-19.09M
2025Q1
273
350.60M
99.12%
-19.40M
2024Q4
262
347.48M
98.58%
-23.77M
2024Q3
257
349.38M
99.14%
-19.72M
2024Q2
260
352.10M
99.92%
-21.43M
2024Q1
247
349.79M
99.91%
-25.18M
2023Q4
237
351.31M
100.35%
-21.66M
2023Q3
219
355.43M
101.52%
-16.80M
2023Q2
207
357.28M
102.06%
-12.23M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Bausch Health Companies Inc
310.45M
87.68%
--
--
Mar 24, 2025
Icahn Associates Corporation
3.50M
0.99%
--
--
Jun 30, 2025
Deutsche Bank Securities Inc.
3.41M
0.96%
-89.90K
-2.57%
Jun 30, 2025
Alberta Investment Management Corporation
3.27M
0.92%
+258.00K
+8.58%
Mar 31, 2025
D. E. Shaw & Co., L.P.
2.61M
0.74%
+728.68K
+38.79%
Jun 30, 2025
GoldenTree Asset Management, LP
2.58M
0.73%
+334.92K
+14.90%
Jun 30, 2025
Oaktree Capital Management, L.P.
2.52M
0.71%
+2.52M
--
Jun 30, 2025
Glenview Capital Management, LLC
1.55M
0.44%
+1.05M
+210.77%
Jun 30, 2025
Whitebox Advisors, L.L.C.
1.29M
0.36%
-331.23K
-20.41%
Jun 30, 2025
Nomura Securities Co., Ltd.
1.26M
0.35%
--
--
Jun 30, 2025
查看更多
持股ETF
更新時間: 11月2日 週日
更新時間: 11月2日 週日
機構名稱
佔比
Ballast Small/Mid Cap ETF
1.45%
Invesco RAFI Developed Mkts ex-US SM ETF
0.03%
BNY Mellon US Small Cap Core Equity ETF
0.03%
Schwab Fundamental International Small Equity ETF
0%
Goldman Sachs MarketBeta US 1000 Equity ETF
0%
Invesco Zacks Mid-Cap ETF
0%
QRAFT AI-Enhanced US Large Cap ETF
0%
AltShares Event-Driven ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
BNY Mellon US Mid Cap Core Equity ETF
0%
查看更多
Ballast Small/Mid Cap ETF
佔比1.45%
Invesco RAFI Developed Mkts ex-US SM ETF
佔比0.03%
BNY Mellon US Small Cap Core Equity ETF
佔比0.03%
Schwab Fundamental International Small Equity ETF
佔比0%
Goldman Sachs MarketBeta US 1000 Equity ETF
佔比0%
Invesco Zacks Mid-Cap ETF
佔比0%
QRAFT AI-Enhanced US Large Cap ETF
佔比0%
AltShares Event-Driven ETF
佔比0%
DFA Dimensional International Core Equity 2 ETF
佔比0%
BNY Mellon US Mid Cap Core Equity ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
